ALLMedicine™ Acute Myelomonocytic Leukemia Center
Research & Reviews 23 results
https://doi.org/10.1186/s12957-021-02399-9 10.1111/ejh.13056 10.1038/sj.leu.2404491 10.1097/MOH.0000000000000571 10.1111/his.13864 10.1016/j.clml.2017.02.027 10.1002/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N 10.3332/ecancer.2020.1160 10.1016/j.blre.2016.04.001 10.1038/sj.bmt.1704223 10.1016/j.leukres.2013.08.017 10.1080/10428190600967022 10.1258/ar.2011.110470 10.12659/AJCR.915453 10.1016/j.hemonc.2018.03.001 10.4103/0973-1482.174174 10.1177/2040620711410774 10.1159/000225262 10.1016/j.clinimag.2005.11.004 10.1308/147870807X227827 10.1093/asj/sju006 10.1097/01.prs.0000286577.70026.5d 10.1097/01.prs.0000286573.72187.6e 10.1136/bmj.f2399
World Journal of Surgical Oncology; Huang C, Fei S et. al.
Sep 29th, 2021 - Myeloid sarcoma (MS) is a tumor secondary to myeloid leukemia that consists of immature granulocytes with or without mature granulocytes and is a rare extramedullary manifestation of acute myeloid leukemia (AML). We report a case of a 34-year-old ...
Medicine Ji J, Li Y et. al.
Apr 14th, 2021 - Pure erythroid leukemia is a rare subcategory of acute myeloid leukemia characterized by predominant immature erythroid population. Its occurrence subsequent to acute myelomonocytic leukemia has not been reported before. We reported this rare case...
Anticancer Research; Thadi A, Lewis L et. al.
Sep 4th, 2020 - Anticancer peptide PNC-27 binds to HDM-2 protein on cancer cell membranes inducing the formation of cytotoxic transmembrane pores. Herein, we investigated HDM-2 membrane expression and the effect of PNC-27 treatment on human non-stem cell acute my...
Molecular Cancer Therapeutics; Anami Y, Deng M et. al.
Sep 4th, 2020 - Acute myeloid leukemia (AML) is the most common and aggressive blood cancer in adults. In particular, significant unmet medical needs exist for effective treatment strategies for acute myelomonocytic leukemia (M4) and acute monocytic leukemia (M5)...
Jul 21st, 2020 - In the 2016 update to the 2008 World Health Organization (WHO) classification system,[1, 2] the category "acute myeloid leukemia [AML] not otherwise specified" [NOS])" excludes AML subtypes associated with recurrent genetic abnormalities such as: ...
News 2 results
Philip R. Cohen, MD
Apr 3rd, 2019 - To the Editor: I read with interest the informative Cutis case report by Krooks and Weatherall1 in which the authors not only described the case of a 66-year-old man whose diagnosis of bone marrow biopsy–confirmed acute myeloid leukemia (AML) pres.
Jan 9th, 2016 - Antilymphocyte globulin (ATG) added to the myeloablative conditioning regimen of patients undergoing allogeneic stem cell transplantation resulted in a lower incidence of chronic graft-versus-host disease (GVHD) compared with conditioning regimens.